English

WAVE LIFE SCIENCES LTD.

EDGAR

WVE Current report (8-K) · filed 2026-10-27

Annual consolidated revenue for 2025: about USD 42.73M, using the latest reported figures. The previous period, 2024, was about USD 108.3M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

13.2 million USD

2026 Q3 · USD

Exact inputs and evidence

Revenue: 13158000 USD Source

Operating margin

-501.95%

2026 Q3 · %

Exact inputs and evidence

Operating Income: -66047000 USD Source
Revenue: 13158000 USD Source

Operating cash flow

-60.1 million USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -173277000 USD Source
Operating Cash Flow: -113135000 USD Source

Free cash flow

-60.2 million USD

2026 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -173277000 USD Source
Operating Cash Flow: -113135000 USD Source
Capital Expenditure: 1337000 USD Source
Capital Expenditure: 1322000 USD Source

Cash and cash equivalents: 197 million USD 2026-09-30 Source
Exact value

197315000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 197 million shares 2026-09-30 Source
Exact value

197213583 shares

Reported share-count change

23.04% · 36.9 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

160288481 shares · 2025-09-30· Source
197213583 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-211 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Net income: -204378000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -151199000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -26087000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -69355000 USD · 2026-04-01 – 2026-06-30 Source
Net income: -61912000 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-207 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Operating cash flow: -187493000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -153717000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -59553000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -113135000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -59553000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -173277000 USD · 2026-01-01 – 2026-09-30 Source
Operating cash flow: -113135000 USD · 2026-01-01 – 2026-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-27.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 11 of 11 periods available· newest 2025-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-60.5%

Prior period

USD 108.3 million

2024-01-01 – 2024-12-31
Current period

USD 42.73 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

42727000 − 108302000 = -65575000 USD

108302000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
42727000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · WAVE LIFE SCIENCES LTD. · 2025-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Year-over-year change in Revenue: -65575000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 42727000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2138282 Filing: 000119312526073472 Input fundies:Revenue: 108302000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2140042 Filing: 000119312526073472
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 107.37 million

Prior period

−USD 97.01 million

2024-01-01 – 2024-12-31
Current period

−USD 204.38 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-204378000 − -97008000 = -107370000 USD

-97008000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-204378000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · WAVE LIFE SCIENCES LTD. · 2025-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Year-over-year change in Net income: -107370000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -204378000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2654399 Filing: 000119312526073472 Input fundies:NetIncome: -97008000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2525014 Filing: 000119312526073472
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 36.47 million

Prior period

−USD 151.03 million

2024-01-01 – 2024-12-31
Current period

−USD 187.49 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-187493000 − -151026000 = -36467000 USD

-151026000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-187493000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · WAVE LIFE SCIENCES LTD. · 2025-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Year-over-year change in Operating cash flow: -36467000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -187493000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2756124 Filing: 000119312526073472 Input fundies:OperatingCashFlow: -151026000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2758018 Filing: 000119312526073472
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-23.5%

Prior period

USD 938,000

2024-01-01 – 2024-12-31
Current period

USD 718,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

718000 − 938000 = -220000 USD

938000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
718000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · WAVE LIFE SCIENCES LTD. · 2025-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Year-over-year change in Capital expenditure: -220000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 718000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2765820 Filing: 000119312526073472 Input fundies:CapitalExpenditure: 938000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2767701 Filing: 000119312526073472
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 42.73 million 100% of revenue
Operating costs Derived USD 258.11 million 604% of revenue
Operating income −USD 215.38 million −504% of revenue
Tax, interest and other Derived −USD 11.01 million −26% of revenue
Net income −USD 204.38 million −478% of revenue

Cash

Operating cash flow −USD 187.49 million −439% of revenue
Capital expenditure USD 718,000 1.7% of revenue
Free cash flow Derived −USD 188.21 million −440% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 5,203% of revenue.
2017 Operating loss: operating costs were 2,730% of revenue.
2018 Operating loss: operating costs were 1,207% of revenue.
2019 Operating loss: operating costs were 1,403% of revenue.
2020 Operating loss: operating costs were 864% of revenue.
2021 Operating loss: operating costs were 410% of revenue.
2022 Operating loss: operating costs were 4,559% of revenue.
2023 Operating loss: operating costs were 160% of revenue.
2024 Operating loss: operating costs were 202% of revenue.
2025 Operating loss: operating costs were 604% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	1092000	56812000 Derived	-55720000	-60000 Derived	-55660000	-37492000 Derived	Source 2016-01-01 – 2016-12-31: 1092000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -55720000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -55660000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -31925000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 5567000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	3893000	106284000 Derived	-102391000	-411000 Derived	-101980000	-102558000 Derived	Source 2017-01-01 – 2017-12-31: 3893000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -102391000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -101980000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -83671000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 18887000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	14414000	173937000 Derived	-159523000	-12870000 Derived	-146653000	-32800000 Derived	Source 2018-01-01 – 2018-12-31: 14414000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -159523000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -146653000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -22862000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 9938000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	15983000	224300000 Derived	-208317000	-14679000 Derived	-193638000	-192149000 Derived	Source 2019-01-01 – 2019-12-31: 15983000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -208317000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -193638000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -188231000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 3918000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	20077000	173454000 Derived	-153377000	-3467000 Derived	-149910000	-117320000 Derived	Source 2020-01-01 – 2020-12-31: 20077000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -153377000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -149910000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -115982000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 1338000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	40964000	167980000 Derived	-127016000	-4771000 Derived	-122245000	-89553000 Derived	Source 2021-01-01 – 2021-12-31: 40964000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -127016000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -122245000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -88993000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 560000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	3649000	166369000 Derived	-162720000	-897000 Derived	-161823000	-129142000 Derived	Source 2022-01-01 – 2022-12-31: 3649000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -162720000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -161823000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -127781000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 1361000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	113305000	181301000 Derived	-67996000	-10483000 Derived	-57513000	-20546000 Derived	Source 2023-01-01 – 2023-12-31: 113305000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -67996000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -57513000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -19431000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 1115000 USD Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	108302000	218705000 Derived	-110403000	-13395000 Derived	-97008000	-151964000 Derived	Source 2024-01-01 – 2024-12-31: 108302000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -110403000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -97008000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -151026000 USD Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 938000 USD Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	42727000	258110000 Derived	-215383000	-11005000 Derived	-204378000	-188211000 Derived	Source 2025-01-01 – 2025-12-31: 42727000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -215383000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -204378000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -187493000 USD Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 718000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 42.7M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	1092000	Revenue: 1092000 Open source
20172017-12-31	Revenue	3893000	Revenue: 3893000 Open source
20182018-12-31	Revenue	14414000	Revenue: 14414000 Open source
20192019-12-31	Revenue	15983000	Revenue: 15983000 Open source
20202020-12-31	Revenue	20077000	Revenue: 20077000 Open source
20212021-12-31	Revenue	40964000	Revenue: 40964000 Open source
20222022-12-31	Revenue	3649000	Revenue: 3649000 Open source
20232023-12-31	Revenue	113305000	Revenue: 113305000 Open source
20242024-12-31	Revenue	108302000	Revenue: 108302000 Open source
20252025-12-31	Revenue	42727000	Revenue: 42727000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-60.5% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	618.4%	Revenue: 1092000 Open source Revenue: 152000 Open source
20172017-12-31	Year over year	256.5%	Revenue: 3893000 Open source Revenue: 1092000 Open source
20182018-12-31	Year over year	270.3%	Revenue: 14414000 Open source Revenue: 3893000 Open source
20192019-12-31	Year over year	10.9%	Revenue: 15983000 Open source Revenue: 14414000 Open source
20202020-12-31	Year over year	25.6%	Revenue: 20077000 Open source Revenue: 15983000 Open source
20212021-12-31	Year over year	104%	Revenue: 40964000 Open source Revenue: 20077000 Open source
20222022-12-31	Year over year	-91.1%	Revenue: 3649000 Open source Revenue: 40964000 Open source
20232023-12-31	Year over year	3,005.1%	Revenue: 113305000 Open source Revenue: 3649000 Open source
20242024-12-31	Year over year	-4.4%	Revenue: 108302000 Open source Revenue: 113305000 Open source
20252025-12-31	Year over year	-60.5%	Revenue: 42727000 Open source Revenue: 108302000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -504.1% 2025

Net margin -478.3% 2025

Free cash flow margin -440.5% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-5,102.6%	Operating Income: -55720000 Open source Revenue: 1092000 Open source
20172017-12-31	Operating margin	-2,630.1%	Operating Income: -102391000 Open source Revenue: 3893000 Open source
20182018-12-31	Operating margin	-1,106.7%	Operating Income: -159523000 Open source Revenue: 14414000 Open source
20192019-12-31	Operating margin	-1,303.4%	Operating Income: -208317000 Open source Revenue: 15983000 Open source
20202020-12-31	Operating margin	-763.9%	Operating Income: -153377000 Open source Revenue: 20077000 Open source
20212021-12-31	Operating margin	-310.1%	Operating Income: -127016000 Open source Revenue: 40964000 Open source
20222022-12-31	Operating margin	-4,459.3%	Operating Income: -162720000 Open source Revenue: 3649000 Open source
20232023-12-31	Operating margin	-60%	Operating Income: -67996000 Open source Revenue: 113305000 Open source
20242024-12-31	Operating margin	-101.9%	Operating Income: -110403000 Open source Revenue: 108302000 Open source
20252025-12-31	Operating margin	-504.1%	Operating Income: -215383000 Open source Revenue: 42727000 Open source
20162016-12-31	Net margin	-5,097.1%	Net Income: -55660000 Open source Revenue: 1092000 Open source
20172017-12-31	Net margin	-2,619.6%	Net Income: -101980000 Open source Revenue: 3893000 Open source
20182018-12-31	Net margin	-1,017.4%	Net Income: -146653000 Open source Revenue: 14414000 Open source
20192019-12-31	Net margin	-1,211.5%	Net Income: -193638000 Open source Revenue: 15983000 Open source
20202020-12-31	Net margin	-746.7%	Net Income: -149910000 Open source Revenue: 20077000 Open source
20212021-12-31	Net margin	-298.4%	Net Income: -122245000 Open source Revenue: 40964000 Open source
20222022-12-31	Net margin	-4,434.7%	Net Income: -161823000 Open source Revenue: 3649000 Open source
20232023-12-31	Net margin	-50.8%	Net Income: -57513000 Open source Revenue: 113305000 Open source
20242024-12-31	Net margin	-89.6%	Net Income: -97008000 Open source Revenue: 108302000 Open source
20252025-12-31	Net margin	-478.3%	Net Income: -204378000 Open source Revenue: 42727000 Open source
20162016-12-31	Free cash flow margin	-3,433.3%	Revenue: 1092000 Open source Operating Cash Flow: -31925000 Open source Capital Expenditure: 5567000 Open source
20172017-12-31	Free cash flow margin	-2,634.4%	Revenue: 3893000 Open source Operating Cash Flow: -83671000 Open source Capital Expenditure: 18887000 Open source
20182018-12-31	Free cash flow margin	-227.6%	Revenue: 14414000 Open source Operating Cash Flow: -22862000 Open source Capital Expenditure: 9938000 Open source
20192019-12-31	Free cash flow margin	-1,202.2%	Revenue: 15983000 Open source Operating Cash Flow: -188231000 Open source Capital Expenditure: 3918000 Open source
20202020-12-31	Free cash flow margin	-584.4%	Revenue: 20077000 Open source Operating Cash Flow: -115982000 Open source Capital Expenditure: 1338000 Open source
20212021-12-31	Free cash flow margin	-218.6%	Revenue: 40964000 Open source Operating Cash Flow: -88993000 Open source Capital Expenditure: 560000 Open source
20222022-12-31	Free cash flow margin	-3,539.1%	Revenue: 3649000 Open source Operating Cash Flow: -127781000 Open source Capital Expenditure: 1361000 Open source
20232023-12-31	Free cash flow margin	-18.1%	Revenue: 113305000 Open source Operating Cash Flow: -19431000 Open source Capital Expenditure: 1115000 Open source
20242024-12-31	Free cash flow margin	-140.3%	Revenue: 108302000 Open source Operating Cash Flow: -151026000 Open source Capital Expenditure: 938000 Open source
20252025-12-31	Free cash flow margin	-440.5%	Revenue: 42727000 Open source Operating Cash Flow: -187493000 Open source Capital Expenditure: 718000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -187.5M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-31925000	Operating Cash Flow: -31925000 Open source
20172017-12-31	Operating cash flow	-83671000	Operating Cash Flow: -83671000 Open source
20182018-12-31	Operating cash flow	-22862000	Operating Cash Flow: -22862000 Open source
20192019-12-31	Operating cash flow	-188231000	Operating Cash Flow: -188231000 Open source
20202020-12-31	Operating cash flow	-115982000	Operating Cash Flow: -115982000 Open source
20212021-12-31	Operating cash flow	-88993000	Operating Cash Flow: -88993000 Open source
20222022-12-31	Operating cash flow	-127781000	Operating Cash Flow: -127781000 Open source
20232023-12-31	Operating cash flow	-19431000	Operating Cash Flow: -19431000 Open source
20242024-12-31	Operating cash flow	-151026000	Operating Cash Flow: -151026000 Open source
20252025-12-31	Operating cash flow	-187493000	Operating Cash Flow: -187493000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -188.2M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	-37492000	Operating Cash Flow: -31925000 Open source Capital Expenditure: 5567000 Open source
20172017-12-31	Free cash flow	-102558000	Operating Cash Flow: -83671000 Open source Capital Expenditure: 18887000 Open source
20182018-12-31	Free cash flow	-32800000	Operating Cash Flow: -22862000 Open source Capital Expenditure: 9938000 Open source
20192019-12-31	Free cash flow	-192149000	Operating Cash Flow: -188231000 Open source Capital Expenditure: 3918000 Open source
20202020-12-31	Free cash flow	-117320000	Operating Cash Flow: -115982000 Open source Capital Expenditure: 1338000 Open source
20212021-12-31	Free cash flow	-89553000	Operating Cash Flow: -88993000 Open source Capital Expenditure: 560000 Open source
20222022-12-31	Free cash flow	-129142000	Operating Cash Flow: -127781000 Open source Capital Expenditure: 1361000 Open source
20232023-12-31	Free cash flow	-20546000	Operating Cash Flow: -19431000 Open source Capital Expenditure: 1115000 Open source
20242024-12-31	Free cash flow	-151964000	Operating Cash Flow: -151026000 Open source Capital Expenditure: 938000 Open source
20252025-12-31	Free cash flow	-188211000	Operating Cash Flow: -187493000 Open source Capital Expenditure: 718000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

17.6% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	13.4%	Total Liabilities: 22074000 Open source Total Assets: 164811000 Open source
20172017-12-31	Liabilities / assets	18.9%	Total Liabilities: 34359000 Open source Total Assets: 181843000 Open source
20182018-12-31	Liabilities / assets	72.6%	Total Liabilities: 214718000 Open source Total Assets: 295940000 Open source
20192019-12-31	Liabilities / assets	74.8%	Total Liabilities: 212644000 Open source Total Assets: 284250000 Open source
20202020-12-31	Liabilities / assets	67.5%	Total Liabilities: 188586000 Open source Total Assets: 279238000 Open source
20212021-12-31	Liabilities / assets	80.5%	Total Liabilities: 166635000 Open source Total Assets: 207007000 Open source
20222022-12-31	Liabilities / assets	125.4%	Total Liabilities: 183603000 Open source Total Assets: 146386000 Open source
20232023-12-31	Liabilities / assets	82.7%	Total Liabilities: 227445000 Open source Total Assets: 274949000 Open source
20242024-12-31	Liabilities / assets	38.3%	Total Liabilities: 134818000 Open source Total Assets: 352207000 Open source
20252025-12-31	Liabilities / assets	17.6%	Total Liabilities: 112268000 Open source Total Assets: 638499000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.47× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	12.5×	Current Assets: 151990000 Open source Current Liabilities: 12155000 Open source
20172017-12-31	Current assets / current liabilities	8.27×	Current Assets: 150488000 Open source Current Liabilities: 18191000 Open source
20182018-12-31	Current assets / current liabilities	1.56×	Current Assets: 202273000 Open source Current Liabilities: 130041000 Open source
20192019-12-31	Current assets / current liabilities	1.57×	Current Assets: 185476000 Open source Current Liabilities: 118153000 Open source
20202020-12-31	Current assets / current liabilities	1.9×	Current Assets: 230042000 Open source Current Liabilities: 121040000 Open source
20212021-12-31	Current assets / current liabilities	2.53×	Current Assets: 162564000 Open source Current Liabilities: 64201000 Open source
20222022-12-31	Current assets / current liabilities	1.38×	Current Assets: 98537000 Open source Current Liabilities: 71521000 Open source
20232023-12-31	Current assets / current liabilities	1.26×	Current Assets: 235373000 Open source Current Liabilities: 186440000 Open source
20242024-12-31	Current assets / current liabilities	2.89×	Current Assets: 320394000 Open source Current Liabilities: 110953000 Open source
20252025-12-31	Current assets / current liabilities	6.47×	Current Assets: 614814000 Open source Current Liabilities: 95065000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 55.66 million Exact value Exact value: -55660000 USD 2016-01-01 – 2016-12-31: -55660000 USD Inspect Net Income Open source Share or cite Citation for Net Income · WAVE LIFE SCIENCES LTD. · 2016-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Net Income: -55660000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -55660000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459019005671/wve-20181231.xml#125900 Filing: 000156459019005671 The citation records this snapshot. The page link may show a newer release later.	−USD 31.93 million Exact value Exact value: -31925000 USD 2016-01-01 – 2016-12-31: -31925000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WAVE LIFE SCIENCES LTD. · 2016-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Operating Cash Flow: -31925000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31925000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459019005671/wve-20181231.xml#153415 Filing: 000156459019005671 The citation records this snapshot. The page link may show a newer release later.	USD 5.57 million Exact value Exact value: 5567000 USD 2016-01-01 – 2016-12-31: 5567000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WAVE LIFE SCIENCES LTD. · 2016-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Capital Expenditure: 5567000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5567000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459019005671/wve-20181231.xml#154257 Filing: 000156459019005671 The citation records this snapshot. The page link may show a newer release later.	−USD 37.49 million Calculation and evidence -31925000 − 5567000 USD Exact free cash flow: -37492000 USD 2016-01-01 – 2016-12-31: -31925000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 5567000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WAVE LIFE SCIENCES LTD. · 2016-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Free cash flow: -37492000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31925000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459019005671/wve-20181231.xml#153415 Filing: 000156459019005671 Input fundies:CapitalExpenditure: 5567000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459019005671/wve-20181231.xml#154257 Filing: 000156459019005671 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 101.98 million Exact value Exact value: -101980000 USD 2017-01-01 – 2017-12-31: -101980000 USD Inspect Net Income Open source Share or cite Citation for Net Income · WAVE LIFE SCIENCES LTD. · 2017-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Net Income: -101980000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -101980000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/wve-10k_20191231.htm#2776397 Filing: 000156459020007972 The citation records this snapshot. The page link may show a newer release later.	−USD 83.67 million Exact value Exact value: -83671000 USD 2017-01-01 – 2017-12-31: -83671000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WAVE LIFE SCIENCES LTD. · 2017-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Operating Cash Flow: -83671000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -83671000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/wve-10k_20191231.htm#2611824 Filing: 000156459020007972 The citation records this snapshot. The page link may show a newer release later.	USD 18.89 million Exact value Exact value: 18887000 USD 2017-01-01 – 2017-12-31: 18887000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WAVE LIFE SCIENCES LTD. · 2017-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Capital Expenditure: 18887000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 18887000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/wve-10k_20191231.htm#2623590 Filing: 000156459020007972 The citation records this snapshot. The page link may show a newer release later.	−USD 102.56 million Calculation and evidence -83671000 − 18887000 USD Exact free cash flow: -102558000 USD 2017-01-01 – 2017-12-31: -83671000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 18887000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WAVE LIFE SCIENCES LTD. · 2017-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Free cash flow: -102558000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -83671000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/wve-10k_20191231.htm#2611824 Filing: 000156459020007972 Input fundies:CapitalExpenditure: 18887000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/wve-10k_20191231.htm#2623590 Filing: 000156459020007972 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 146.65 million Exact value Exact value: -146653000 USD 2018-01-01 – 2018-12-31: -146653000 USD Inspect Net Income Open source Share or cite Citation for Net Income · WAVE LIFE SCIENCES LTD. · 2018-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Net Income: -146653000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -146653000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/wve-10k_20191231.htm#2372918 Filing: 000156459020007972 The citation records this snapshot. The page link may show a newer release later.	−USD 22.86 million Exact value Exact value: -22862000 USD 2018-01-01 – 2018-12-31: -22862000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WAVE LIFE SCIENCES LTD. · 2018-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Operating Cash Flow: -22862000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22862000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/wve-10k_20191231.htm#2609835 Filing: 000156459020007972 The citation records this snapshot. The page link may show a newer release later.	USD 9.94 million Exact value Exact value: 9938000 USD 2018-01-01 – 2018-12-31: 9938000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WAVE LIFE SCIENCES LTD. · 2018-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Capital Expenditure: 9938000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9938000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/wve-10k_20191231.htm#2621677 Filing: 000156459020007972 The citation records this snapshot. The page link may show a newer release later.	−USD 32.8 million Calculation and evidence -22862000 − 9938000 USD Exact free cash flow: -32800000 USD 2018-01-01 – 2018-12-31: -22862000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 9938000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WAVE LIFE SCIENCES LTD. · 2018-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Free cash flow: -32800000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22862000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/wve-10k_20191231.htm#2609835 Filing: 000156459020007972 Input fundies:CapitalExpenditure: 9938000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459020007972/wve-10k_20191231.htm#2621677 Filing: 000156459020007972 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 193.64 million Exact value Exact value: -193638000 USD 2019-01-01 – 2019-12-31: -193638000 USD Inspect Net Income Open source Share or cite Citation for Net Income · WAVE LIFE SCIENCES LTD. · 2019-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Net Income: -193638000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -193638000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459021010718/wve-10k_20201231.htm#2109661 Filing: 000156459021010718 The citation records this snapshot. The page link may show a newer release later.	−USD 188.23 million Exact value Exact value: -188231000 USD 2019-01-01 – 2019-12-31: -188231000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WAVE LIFE SCIENCES LTD. · 2019-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Operating Cash Flow: -188231000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -188231000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459021010718/wve-10k_20201231.htm#2327410 Filing: 000156459021010718 The citation records this snapshot. The page link may show a newer release later.	USD 3.92 million Exact value Exact value: 3918000 USD 2019-01-01 – 2019-12-31: 3918000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WAVE LIFE SCIENCES LTD. · 2019-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Capital Expenditure: 3918000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3918000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459021010718/wve-10k_20201231.htm#2335347 Filing: 000156459021010718 The citation records this snapshot. The page link may show a newer release later.	−USD 192.15 million Calculation and evidence -188231000 − 3918000 USD Exact free cash flow: -192149000 USD 2019-01-01 – 2019-12-31: -188231000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 3918000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WAVE LIFE SCIENCES LTD. · 2019-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Free cash flow: -192149000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -188231000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459021010718/wve-10k_20201231.htm#2327410 Filing: 000156459021010718 Input fundies:CapitalExpenditure: 3918000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459021010718/wve-10k_20201231.htm#2335347 Filing: 000156459021010718 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 149.91 million Exact value Exact value: -149910000 USD 2020-01-01 – 2020-12-31: -149910000 USD Inspect Net Income Open source Share or cite Citation for Net Income · WAVE LIFE SCIENCES LTD. · 2020-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Net Income: -149910000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -149910000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459022008414/wve-10k_20211231.htm#2114102 Filing: 000156459022008414 The citation records this snapshot. The page link may show a newer release later.	−USD 115.98 million Exact value Exact value: -115982000 USD 2020-01-01 – 2020-12-31: -115982000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WAVE LIFE SCIENCES LTD. · 2020-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Operating Cash Flow: -115982000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -115982000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459022008414/wve-10k_20211231.htm#2317293 Filing: 000156459022008414 The citation records this snapshot. The page link may show a newer release later.	USD 1.34 million Exact value Exact value: 1338000 USD 2020-01-01 – 2020-12-31: 1338000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WAVE LIFE SCIENCES LTD. · 2020-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Capital Expenditure: 1338000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1338000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459022008414/wve-10k_20211231.htm#2325201 Filing: 000156459022008414 The citation records this snapshot. The page link may show a newer release later.	−USD 117.32 million Calculation and evidence -115982000 − 1338000 USD Exact free cash flow: -117320000 USD 2020-01-01 – 2020-12-31: -115982000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 1338000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WAVE LIFE SCIENCES LTD. · 2020-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Free cash flow: -117320000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -115982000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459022008414/wve-10k_20211231.htm#2317293 Filing: 000156459022008414 Input fundies:CapitalExpenditure: 1338000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000156459022008414/wve-10k_20211231.htm#2325201 Filing: 000156459022008414 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 122.25 million Exact value Exact value: -122245000 USD 2021-01-01 – 2021-12-31: -122245000 USD Inspect Net Income Open source Share or cite Citation for Net Income · WAVE LIFE SCIENCES LTD. · 2021-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Net Income: -122245000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -122245000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000095017023009319/wve-20221231.htm#2720014 Filing: 000095017023009319 The citation records this snapshot. The page link may show a newer release later.	−USD 88.99 million Exact value Exact value: -88993000 USD 2021-01-01 – 2021-12-31: -88993000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WAVE LIFE SCIENCES LTD. · 2021-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Operating Cash Flow: -88993000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -88993000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000095017023009319/wve-20221231.htm#2972238 Filing: 000095017023009319 The citation records this snapshot. The page link may show a newer release later.	USD 560,000 Exact value Exact value: 560000 USD 2021-01-01 – 2021-12-31: 560000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WAVE LIFE SCIENCES LTD. · 2021-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Capital Expenditure: 560000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 560000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000095017023009319/wve-20221231.htm#2980186 Filing: 000095017023009319 The citation records this snapshot. The page link may show a newer release later.	−USD 89.55 million Calculation and evidence -88993000 − 560000 USD Exact free cash flow: -89553000 USD 2021-01-01 – 2021-12-31: -88993000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 560000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WAVE LIFE SCIENCES LTD. · 2021-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Free cash flow: -89553000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -88993000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000095017023009319/wve-20221231.htm#2972238 Filing: 000095017023009319 Input fundies:CapitalExpenditure: 560000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000095017023009319/wve-20221231.htm#2980186 Filing: 000095017023009319 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 161.82 million Exact value Exact value: -161823000 USD 2022-01-01 – 2022-12-31: -161823000 USD Inspect Net Income Open source Share or cite Citation for Net Income · WAVE LIFE SCIENCES LTD. · 2022-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Net Income: -161823000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -161823000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000095017025031322/wve-20241231.htm#2416859 Filing: 000095017025031322 The citation records this snapshot. The page link may show a newer release later.	−USD 127.78 million Exact value Exact value: -127781000 USD 2022-01-01 – 2022-12-31: -127781000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WAVE LIFE SCIENCES LTD. · 2022-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Operating Cash Flow: -127781000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -127781000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000095017025031322/wve-20241231.htm#2759643 Filing: 000095017025031322 The citation records this snapshot. The page link may show a newer release later.	USD 1.36 million Exact value Exact value: 1361000 USD 2022-01-01 – 2022-12-31: 1361000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WAVE LIFE SCIENCES LTD. · 2022-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Capital Expenditure: 1361000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1361000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000095017025031322/wve-20241231.htm#2768462 Filing: 000095017025031322 The citation records this snapshot. The page link may show a newer release later.	−USD 129.14 million Calculation and evidence -127781000 − 1361000 USD Exact free cash flow: -129142000 USD 2022-01-01 – 2022-12-31: -127781000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 1361000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WAVE LIFE SCIENCES LTD. · 2022-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Free cash flow: -129142000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -127781000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000095017025031322/wve-20241231.htm#2759643 Filing: 000095017025031322 Input fundies:CapitalExpenditure: 1361000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000095017025031322/wve-20241231.htm#2768462 Filing: 000095017025031322 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 57.51 million Exact value Exact value: -57513000 USD 2023-01-01 – 2023-12-31: -57513000 USD Inspect Net Income Open source Share or cite Citation for Net Income · WAVE LIFE SCIENCES LTD. · 2023-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Net Income: -57513000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -57513000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2395314 Filing: 000119312526073472 The citation records this snapshot. The page link may show a newer release later.	−USD 19.43 million Exact value Exact value: -19431000 USD 2023-01-01 – 2023-12-31: -19431000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WAVE LIFE SCIENCES LTD. · 2023-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Operating Cash Flow: -19431000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19431000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2759912 Filing: 000119312526073472 The citation records this snapshot. The page link may show a newer release later.	USD 1.12 million Exact value Exact value: 1115000 USD 2023-01-01 – 2023-12-31: 1115000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WAVE LIFE SCIENCES LTD. · 2023-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Capital Expenditure: 1115000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1115000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2769582 Filing: 000119312526073472 The citation records this snapshot. The page link may show a newer release later.	−USD 20.55 million Calculation and evidence -19431000 − 1115000 USD Exact free cash flow: -20546000 USD 2023-01-01 – 2023-12-31: -19431000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 1115000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WAVE LIFE SCIENCES LTD. · 2023-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Free cash flow: -20546000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19431000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2759912 Filing: 000119312526073472 Input fundies:CapitalExpenditure: 1115000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2769582 Filing: 000119312526073472 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 97.01 million Exact value Exact value: -97008000 USD 2024-01-01 – 2024-12-31: -97008000 USD Inspect Net Income Open source Share or cite Citation for Net Income · WAVE LIFE SCIENCES LTD. · 2024-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Net Income: -97008000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -97008000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2525014 Filing: 000119312526073472 The citation records this snapshot. The page link may show a newer release later.	−USD 151.03 million Exact value Exact value: -151026000 USD 2024-01-01 – 2024-12-31: -151026000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WAVE LIFE SCIENCES LTD. · 2024-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Operating Cash Flow: -151026000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -151026000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2758018 Filing: 000119312526073472 The citation records this snapshot. The page link may show a newer release later.	USD 938,000 Exact value Exact value: 938000 USD 2024-01-01 – 2024-12-31: 938000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WAVE LIFE SCIENCES LTD. · 2024-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Capital Expenditure: 938000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 938000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2767701 Filing: 000119312526073472 The citation records this snapshot. The page link may show a newer release later.	−USD 151.96 million Calculation and evidence -151026000 − 938000 USD Exact free cash flow: -151964000 USD 2024-01-01 – 2024-12-31: -151026000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 938000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WAVE LIFE SCIENCES LTD. · 2024-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Free cash flow: -151964000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -151026000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2758018 Filing: 000119312526073472 Input fundies:CapitalExpenditure: 938000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2767701 Filing: 000119312526073472 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 204.38 million Exact value Exact value: -204378000 USD 2025-01-01 – 2025-12-31: -204378000 USD Inspect Net Income Open source Share or cite Citation for Net Income · WAVE LIFE SCIENCES LTD. · 2025-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Net Income: -204378000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -204378000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2654399 Filing: 000119312526073472 The citation records this snapshot. The page link may show a newer release later.	−USD 187.49 million Exact value Exact value: -187493000 USD 2025-01-01 – 2025-12-31: -187493000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · WAVE LIFE SCIENCES LTD. · 2025-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Operating Cash Flow: -187493000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -187493000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2756124 Filing: 000119312526073472 The citation records this snapshot. The page link may show a newer release later.	USD 718,000 Exact value Exact value: 718000 USD 2025-01-01 – 2025-12-31: 718000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · WAVE LIFE SCIENCES LTD. · 2025-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Capital Expenditure: 718000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 718000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2765820 Filing: 000119312526073472 The citation records this snapshot. The page link may show a newer release later.	−USD 188.21 million Calculation and evidence -187493000 − 718000 USD Exact free cash flow: -188211000 USD 2025-01-01 – 2025-12-31: -187493000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 718000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · WAVE LIFE SCIENCES LTD. · 2025-12-31 WAVE LIFE SCIENCES LTD. (edgar:1631574) Free cash flow: -188211000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:04:46Z Snapshot: 757f6832a666710b97ff62c0d77909e2acd3b077aff68d79fee6c7fdea065644 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1631574?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -187493000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2756124 Filing: 000119312526073472 Input fundies:CapitalExpenditure: 718000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1631574/000119312526073472/wve-20251231.htm#2765820 Filing: 000119312526073472 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

72 filings · 3,190 latest values · 3,190 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001631574, 1631574, WVE, edgar:1631574

Also known as WAVE LIFE SCIENCES LTD., WAVE LIFE SCIENCES, INC., WAVE Life Sciences Ltd., Wave Life Sciences LTD., Wave Life Sciences Ltd., Wave Life Sciences Pte Ltd, Wave Life Sciences, Inc.

WAVE LIFE SCIENCES LTD.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation